Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2021-2026
According to this study, over the next five years the Follicular Lymphoma Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2026, from $ xx million in 2020.Specially this report presents the global revenue market share of key companies in Follicular Lymphoma Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Follicular Lymphoma Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by product type:
Chemotherapy Drug
Monoclonal Antibody
Kinase Inhibitor
CAR T-cell Therapy
Others
Segmentation by Patient Age:
< 55
55-64
65+
This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Genentech (Roche)
Bristol-Myers Squibb
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Jazz Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Follicular Lymphoma Drugs Market Size 2021-2026
2.1.2 Follicular Lymphoma Drugs Market Size CAGR by Region
2.2 Follicular Lymphoma Drugs Segment by Type
2.2.1 Chemotherapy Drug
2.2.2 Monoclonal Antibody
2.2.3 Kinase Inhibitor
2.2.4 CAR T-cell Therapy
2.2.5 Others
2.3 Follicular Lymphoma Drugs Market Size by Type
2.3.1 Global Follicular Lymphoma Drugs Market Size Market Share by Type (2021-2026)
2.3.2 Global Follicular Lymphoma Drugs Market Size Growth Rate by Type (2021-2026)
2.4 Follicular Lymphoma Drugs Segment by Patient Age
2.4.1 < 55
2.4.2 55-64
2.4.3 65+
2.5 Follicular Lymphoma Drugs Market Size by Patient Age
2.5.1 Global Follicular Lymphoma Drugs Market Size Market Share by Patient Age (2021-2026)
2.5.2 Global Follicular Lymphoma Drugs Market Size Growth Rate by Patient Age (2021-2026)
3 Follicular Lymphoma Drugs Key Players
3.1 Date of Key Players Enter into Follicular Lymphoma Drugs
3.2 Key Players Follicular Lymphoma Drugs Product Offered
3.3 Key Players Follicular Lymphoma Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Follicular Lymphoma Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Follicular Lymphoma Drugs by Regions
4.1 Follicular Lymphoma Drugs Market Size by Regions (2021-2026)
4.2 Americas Follicular Lymphoma Drugs Market Size Growth (2021-2026)
4.3 APAC Follicular Lymphoma Drugs Market Size Growth (2021-2026)
4.4 Europe Follicular Lymphoma Drugs Market Size Growth (2021-2026)
5 Americas
5.1 Americas Follicular Lymphoma Drugs Market Size by Countries (2021-2026)
5.2 Americas Follicular Lymphoma Drugs Market Size by Type (2021-2026)
5.3 Americas Follicular Lymphoma Drugs Market Size by Patient Age (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Follicular Lymphoma Drugs Market Size by Regions
6.2 APAC Follicular Lymphoma Drugs Market Size by Type (2021-2026)
6.3 APAC Follicular Lymphoma Drugs Market Size by Patient Age (2021-2026)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Follicular Lymphoma Drugs by Countries (2021-2026)
7.2 Europe Follicular Lymphoma Drugs Market Size by Type (2021-2026)
7.3 Europe Follicular Lymphoma Drugs Market Size by Patient Age (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in Follicular Lymphoma Drugs
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……
10 Key Players Analysis
10.1 Genentech (Roche)
10.1.1 Genentech (Roche) Company Details
10.1.2 Genentech (Roche) Follicular Lymphoma Drugs Product Offered
10.1.3 Genentech (Roche) Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.1.4 Genentech (Roche) Main Business Overview
10.1.5 Genentech (Roche) News
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Details
10.2.2 Bristol-Myers Squibb Follicular Lymphoma Drugs Product Offered
10.2.3 Bristol-Myers Squibb Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.2.4 Bristol-Myers Squibb Main Business Overview
10.2.5 Bristol-Myers Squibb News
10.3 Gilead Sciences
10.3.1 Gilead Sciences Company Details
10.3.2 Gilead Sciences Follicular Lymphoma Drugs Product Offered
10.3.3 Gilead Sciences Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.3.4 Gilead Sciences Main Business Overview
10.3.5 Gilead Sciences News
10.4 TG Therapeutics
10.4.1 TG Therapeutics Company Details
10.4.2 TG Therapeutics Follicular Lymphoma Drugs Product Offered
10.4.3 TG Therapeutics Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.4.4 TG Therapeutics Main Business Overview
10.4.5 TG Therapeutics News
10.5 Bayer
10.5.1 Bayer Company Details
10.5.2 Bayer Follicular Lymphoma Drugs Product Offered
10.5.3 Bayer Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.5.4 Bayer Main Business Overview
10.5.5 Bayer News
10.6 Secura Bio
10.6.1 Secura Bio Company Details
10.6.2 Secura Bio Follicular Lymphoma Drugs Product Offered
10.6.3 Secura Bio Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.6.4 Secura Bio Main Business Overview
10.6.5 Secura Bio News
10.7 Epizyme
10.7.1 Epizyme Company Details
10.7.2 Epizyme Follicular Lymphoma Drugs Product Offered
10.7.3 Epizyme Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.7.4 Epizyme Main Business Overview
10.7.5 Epizyme News
10.8 Jazz Pharmaceuticals
10.8.1 Jazz Pharmaceuticals Company Details
10.8.2 Jazz Pharmaceuticals Follicular Lymphoma Drugs Product Offered
10.8.3 Jazz Pharmaceuticals Follicular Lymphoma Drugs Market Size (2021 VS 2026)
10.8.4 Jazz Pharmaceuticals Main Business Overview
10.8.5 Jazz Pharmaceuticals News
11 Research Findings and Conclusion
List of Tables
Table 1. Follicular Lymphoma Drugs Market Size CAGR by Region (2021-2026) ($ Millions)
Table 2. Major Players of Chemotherapy Drug
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Kinase Inhibitor
Table 5. Major Players of CAR T-cell Therapy
Table 6. Major Players of Others
Table 7. Global Follicular Lymphoma Drugs Market Size by Type (2021-2026) ($ Millions)
Table 8. Global Follicular Lymphoma Drugs Market Size Market Share by Type (2021-2026)
Table 9. Global Follicular Lymphoma Drugs Market Size by Patient Age (2021-2026) ($ Millions)
Table 10. Global Follicular Lymphoma Drugs Market Size Market Share by Patient Age (2021-2026)
Table 11. Date of Global Key Players Enter into Follicular Lymphoma Drugs Market
Table 12. Global Key Players Follicular Lymphoma Drugs Product Offered
Table 13. Key Players Follicular Lymphoma Drugs Funding/Investment ($ Millions)
Table 14. Funding/Investment by Regions
Table 15. Funding/Investment by End Industry
Table 16. Key Players Follicular Lymphoma Drugs Valuation & Market Capitalization ($ Millions)
Table 17. Key Players Mergers & Acquisitions, Expansion Plans
Table 18. Follicular Lymphoma Drugs New Product/Technology Launches
Table 19. Follicular Lymphoma Drugs Industry Partnerships, Agreements, and Collaborations
Table 20. Follicular Lymphoma Drugs Industry Mergers and Acquisitions
Table 21. Global Follicular Lymphoma Drugs Market Size by Regions 2021-2026 ($ Millions)
Table 22. Global Follicular Lymphoma Drugs Market Size Market Share by Regions 2021-2026
Table 23. Americas Follicular Lymphoma Drugs Market Size by Countries (2021-2026) ($ Millions)
Table 24. Americas Follicular Lymphoma Drugs Market Size Market Share by Countries (2021-2026)
Table 25. Americas Follicular Lymphoma Drugs Market Size by Type (2021-2026) ($ Millions)
Table 26. Americas Follicular Lymphoma Drugs Market Size Market Share by Type (2021-2026)
Table 27. Americas Follicular Lymphoma Drugs Market Size by Patient Age (2021-2026) ($ Millions)
Table 28. Americas Follicular Lymphoma Drugs Market Size Market Share by Patient Age (2021-2026)
Table 29. APAC Follicular Lymphoma Drugs Market Size by Regions (2021-2026) ($ Millions)
Table 30. APAC Follicular Lymphoma Drugs Market Size Market Share by Regions (2021-2026)
Table 31. APAC Follicular Lymphoma Drugs Market Size by Type (2021-2026) ($ Millions)
Table 32. APAC Follicular Lymphoma Drugs Market Size Market Share by Type (2021-2026)
Table 33. APAC Follicular Lymphoma Drugs Market Size by Patient Age (2021-2026) ($ Millions)
Table 34. APAC Follicular Lymphoma Drugs Market Size Market Share by Patient Age (2021-2026)
Table 35. Europe Follicular Lymphoma Drugs Market Size by Countries (2021-2026) ($ Millions)
Table 36. Europe Follicular Lymphoma Drugs Market Size Market Share by Countries (2021-2026)
Table 37. Europe Follicular Lymphoma Drugs Market Size by Type (2021-2026) ($ Millions)
Table 38. Europe Follicular Lymphoma Drugs Market Size Market Share by Type (2021-2026)
Table 39. Europe Follicular Lymphoma Drugs Market Size by Patient Age (2021-2026) ($ Millions)
Table 40. Europe Follicular Lymphoma Drugs Market Size Market Share by Patient Age (2021-2026)
Table 41. Key and Potential Regions of Follicular Lymphoma Drugs
Table 42. Key Application and Potential Industries of Follicular Lymphoma Drugs
Table 43. Key Challenges of Follicular Lymphoma Drugs
Table 44. Key Trends of Follicular Lymphoma Drugs
Table 45. Company A Company Details
Table 46. Companies Invested by Company A
Table 47. Company A Key Development and Market Layout
Table 48. Company B Company Details
Table 49. Companies Invested by Company B
Table 50. Company B Key Development and Market Layout
Table 51. Company C Company Details
Table 52. Companies Invested by Company C
Table 53. Company C Key Development and Market Layout
Table 54. Company C Company Details
Table 55. Companies Invested by Company C
Table 56. Company C Key Development and Market Layout
Table 57. Genentech (Roche) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Genentech (Roche) Follicular Lymphoma Drugs Market Size (2021 VS 2026)
Table 59. Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Bristol-Myers Squibb Follicular Lymphoma Drugs Market Size (2021 VS 2026)
Table 61. Gilead Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Gilead Sciences Follicular Lymphoma Drugs Market Size (2021 VS 2026)
Table 63. TG Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. TG Therapeutics Follicular Lymphoma Drugs Market Size (2021 VS 2026)
Table 65. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. Bayer Follicular Lymphoma Drugs Market Size (2021 VS 2026)
Table 67. Secura Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Secura Bio Follicular Lymphoma Drugs Market Size (2021 VS 2026)
Table 69. Epizyme Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. Epizyme Follicular Lymphoma Drugs Market Size (2021 VS 2026)
Table 71. Jazz Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. Jazz Pharmaceuticals Follicular Lymphoma Drugs Market Size (2021 VS 2026)
List of Figures
Figure 1. Picture of Follicular Lymphoma Drugs
Figure 2. Follicular Lymphoma Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Follicular Lymphoma Drugs Market Size Growth Rate 2021-2026 ($ Millions)
Figure 7. Follicular Lymphoma Drugs Market Size by Region (2021 & 2026) ($ millions)
Figure 8. Global Follicular Lymphoma Drugs Market Size Market Share by Type (2021-2026)
Figure 9. Global Chemotherapy Drug Market Size Growth Rate
Figure 10. Global Monoclonal Antibody Market Size Growth Rate
Figure 11. Global Kinase Inhibitor Market Size Growth Rate
Figure 12. Global CAR T-cell Therapy Market Size Growth Rate
Figure 13. Global Others Market Size Growth Rate
Figure 14. Follicular Lymphoma Drugs in < 55
Figure 15. Global Follicular Lymphoma Drugs Market: < 55 (2021-2026) ($ Millions)
Figure 16. Follicular Lymphoma Drugs in 55-64
Figure 17. Global Follicular Lymphoma Drugs Market: 55-64 (2021-2026) ($ Millions)
Figure 18. Follicular Lymphoma Drugs in 65+
Figure 19. Global Follicular Lymphoma Drugs Market: 65+ (2021-2026) ($ Millions)
Figure 20. Global Follicular Lymphoma Drugs Market Size Market Share by Patient Age (2021-2026)
Figure 21. Global Follicular Lymphoma Drugs Market Size in < 55 Growth Rate
Figure 22. Global Follicular Lymphoma Drugs Market Size in 55-64 Growth Rate
Figure 23. Global Follicular Lymphoma Drugs Market Size in 65+ Growth Rate
Figure 24. Funding/Investment
Figure 25. Global Follicular Lymphoma Drugs Market Size Market Share by Regions 2021-2026
Figure 26. Americas Follicular Lymphoma Drugs Market Size 2021-2026 ($ Millions)
Figure 27. APAC Follicular Lymphoma Drugs Market Size 2021-2026 ($ Millions)
Figure 28. Europe Follicular Lymphoma Drugs Market Size 2021-2026 ($ Millions)
Figure 29. Americas Follicular Lymphoma Drugs Market Size Market Share by Countries in 2020
Figure 30. Americas Follicular Lymphoma Drugs Market Size Market Share by Type in 2020
Figure 31. Americas Follicular Lymphoma Drugs Market Size Market Share by Patient Age in 2020
Figure 32. United States Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 33. Canada Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 34. Mexico Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 35. Brazil Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 36. APAC Follicular Lymphoma Drugs Market Size Market Share by Regions in 2020
Figure 37. APAC Follicular Lymphoma Drugs Market Size Market Share by Type in 2020
Figure 38. APAC Follicular Lymphoma Drugs Market Size Market Share by Patient Age in 2020
Figure 39. China Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 40. Japan Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 41. Korea Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 42. Southeast Asia Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 43. India Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 44. Australia Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 45. Europe Follicular Lymphoma Drugs Market Size Market Share by Countries in 2020
Figure 46. Europe Follicular Lymphoma Drugs Market Size Market Share by Type in 2020
Figure 47. Europe Follicular Lymphoma Drugs Market Size Market Share by Patient Age in 2020
Figure 48. Germany Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 49. France Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 50. UK Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 51. Italy Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 52. Russia Follicular Lymphoma Drugs Market Size Growth 2021-2026 ($ Millions)
